These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 21799367)

  • 41. Importance of adrenal incidentaloma in patients with a history of malignancy.
    Frilling A; Tecklenborg K; Weber F; Kühl H; Müller S; Stamatis G; Broelsch C
    Surgery; 2004 Dec; 136(6):1289-96. PubMed ID: 15657589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT.
    Fikri AS; Kroiss A; Ahmad AZ; Zanariah H; Lau WF; Uprimny C; Donnemiller E; Kendler D; Nordin AJ; Virgolini IJ
    Acta Radiol; 2014 Jun; 55(5):631-40. PubMed ID: 24037430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma.
    Sachpekidis C; Goldschmidt H; Dimitrakopoulou-Strauss A
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31905752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upper pole of a duplex kidney mimicking adrenal incidentaloma in 18F-fluoro-2-deoxy-D-glucose positron emission tomography: a pitfall in diagnosis.
    Chan SC; Yen TC; Ng KK
    Br J Radiol; 2006 Aug; 79(944):e50-2. PubMed ID: 16861318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy.
    Wong C; Lin M; Chicco A; Benson R
    Acta Radiol; 2011 Oct; 52(8):899-904. PubMed ID: 21873505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Positron emission tomography (PET) with fludeoxyglucose F 18 in the study of adrenal masses: comparison of benign and malignant lesions].
    Maurea S; Mainolfi C; Wang H; Varrella P; Panico MR; Klain M; Rossi R; Cremona F; Bazzicalupo L; Salvatore M
    Radiol Med; 1996 Dec; 92(6):782-7. PubMed ID: 9122472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
    Erasmus JJ; Patz EF; McAdams HP; Murray JG; Herndon J; Coleman RE; Goodman PC
    AJR Am J Roentgenol; 1997 May; 168(5):1357-60. PubMed ID: 9129444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience.
    Komori T; Narabayashi I; Matsumura K; Matsuki M; Akagi H; Ogura Y; Aga F; Adachi I
    Ann Nucl Med; 2007 Jun; 21(4):209-15. PubMed ID: 17581719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
    Treglia G; Castaldi P; Villani MF; Perotti G; Filice A; Ambrosini V; Cremonini N; Versari A; Fanti S; Giordano A; Rufini V
    Recent Results Cancer Res; 2013; 194():385-93. PubMed ID: 22918771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contemporary imaging of incidentally discovered adrenal masses.
    Wale DJ; Wong KK; Viglianti BL; Rubello D; Gross MD
    Biomed Pharmacother; 2017 Mar; 87():256-262. PubMed ID: 28063406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PET in the diagnostic evaluation of adrenal tumors.
    Gross MD; Avram A; Fig LM; Fanti S; Al-Nahhas A; Rubello D
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):272-83. PubMed ID: 17464268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers.
    Gauthé M; Richard-Molard M; Cacheux W; Michel P; Jouve JL; Mitry E; Alberini JL; Lièvre A;
    Dig Liver Dis; 2015 Jun; 47(6):443-54. PubMed ID: 25766918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Application progress of 18F-FDG positron emission tomograph in differentiated thyroid cancer].
    Huang R; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Apr; 31(2):445-51. PubMed ID: 25039157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
    Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
    Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.